Urokinase Antigen in Plasma of Patients with Liver Cirrhosis and Hepatoma

Summary Plasma urokinase antigen levels were studied in 78 patients suffering from liver diseases. Blood was drawn before any specific medication was initiated. Impairment of liver function was comparable in all patients. In both groups of cirrhotic liver disease (alcoholic and non-alcoholic), normal levels of plasma urokinase antigen were found as compared to age-matched control groups. In both groups of patients with hepatomas (with or without a history of liver cirrhosis), however, significantly increased plasma urokinase antigen levels could be determined. These data indicate that an increase in plasma urokinase antigen might rather relate to malignant growth in liver disease than to impaired liver function.

[1]  B. Binder,et al.  Increased urokinase activity to antigen ratio in human renal‐cell carcinoma , 1985, International journal of cancer.

[2]  B. Binder,et al.  Urokinase antigen in plasma: age and sex dependent variations. , 1984, Thrombosis research.

[3]  B. Bennett,et al.  Plasminogen activators in alcoholic cirrhosis: demonstration of increased tissue type and urokinase type activator. , 1984, Journal of clinical pathology.

[4]  K. Huber,et al.  Characterization of a specific anti-human urokinase antibody: development of a sensitive competition radioimmunoassay for urokinase antigen. , 1984, The Journal of laboratory and clinical medicine.

[5]  C. Korninger,et al.  Turnover of Human Extrinsic (Tissue-Type) Plasminogen Activator in Rabbits , 1981, Thrombosis and Haemostasis.

[6]  T. Kosugi,et al.  Urokinase inactivation rate in the rabbit: effect of circulatory isolation of the liver, spleen and kidneys. , 1978, Haemostasis.

[7]  L. Sherman,et al.  Release of Fibrinolytic Enzymes by Macrophages in Response to Soluble Fibrin , 1981, Thrombosis and Haemostasis.

[8]  J. Vassalli,et al.  Macrophage plasminogen activator: Modulation of enzyme production by anti-inflammatory steroids, mitotic inhibitors, and cyclic nucleotides , 1976, Cell.

[9]  C. Grossi,et al.  Coagulation defects in patients with cirrhosis of the liver undergoing portasystemic shunts. , 1962, American journal of surgery.

[10]  C. Grossi,et al.  Studies on Spontaneous Fibrinolytic Activity In Patients with Cirrhosis of the Liver and Its Inhibition by Epsilon Amino Caproic Acid , 1961, Annals of surgery.

[11]  J. Bunker,et al.  Coagulation defects in liver disease and response to transfusion during surgery. , 1959, The American journal of medicine.

[12]  H. Kwaan,et al.  Plasma fibrinolytic activity in cirrhosis of the liver. , 1956, Lancet.